title: Matrix metalloproteinase-2 is elevated in midtrimester amniotic fluid prior to the development of preeclampsia.
abstract: OBJECTIVE
  To evaluate levels of matrix metalloproteinases (MMP) and their inhibitors (TIMP) in second trimester amniotic fluid of women with hypertensive disorders compared to normotensive women.
  
  
  METHODS
  Amniotic fluid was obtained from 133 women undergoing genetic second trimester amniocentesis. Zymography was performed for MMP characterization and an MMP-2 ELISA kit was used to determine MMP-2 levels. TIMP-2 expression was evaluated using western blot.
  
  
  RESULTS
  Mean amniotic fluid MMP-2 and TIMP-2 levels were significantly higher in women who developed a hypertensive disorder compared to normotensive women (P < 0.0004 and P < 0.01, respectively). When subdivided into subgroups, amniotic fluid from women who eventually developed preeclampsia or superimposed preeclampsia showed significantly higher MMP-2 levels than normotensive women (P < 0.05). However, no statistical difference in MMP-2 levels was found between patients with gestational hypertension and normotensive patients.
  
  
  CONCLUSIONS
  Higher amniotic fluid MMP-2 and TIMP-2 levels are found in women who eventually develop preeclampsia.
authors.affiliation: Department of Obstetrics and Gynecology, Ha'Emek Medical Center, Afula, Israel. michal_la@clalit.org.il
authors.forename: Michal
authors.initials: M
authors.lastname: Lavee
authors.forename: Shlomit
authors.initials: S
authors.lastname: Goldman
authors.forename: Etty
authors.initials: E
authors.lastname: Daniel-Spiegel
authors.forename: Eliezer
authors.initials: E
authors.lastname: Shalev
mesh_terms: D000653:Amniotic Fluid / Q000378:metabolism*; D005260:Female; D006801:Humans; D046110:Hypertension, Pregnancy-Induced / Q000378:metabolism; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism*; D011225:Pre-Eclampsia / Q000378:metabolism*; D011247:Pregnancy; D011262:Pregnancy Trimester, Second / Q000502:physiology*; D019716:Tissue Inhibitor of Metalloproteinase-2 / Q000378:metabolism*
chemical_list: D019716:Tissue Inhibitor of Metalloproteinase-2; D020778:Matrix Metalloproteinase 2
references.citation: Lancet. 2001 Jan 6;357(9249):53-6
references.pmid: 11197372
references.citation: Microvasc Res. 1999 May;57(3):340-6
references.pmid: 10329260
references.citation: Biol Reprod. 2003 Jul;69(1):1-7
references.pmid: 12620937
references.citation: Genes Dev. 2000 Sep 1;14(17):2123-33
references.pmid: 10970876
references.citation: Eur J Obstet Gynecol Reprod Biol. 2003 Dec 10;111(2):109-21
references.pmid: 14597237
references.citation: Hypertens Pregnancy. 2007;26(2):189-99
references.pmid: 17469009
references.citation: Arterioscler Thromb Vasc Biol. 2001 Jul;21(7):1104-17
references.pmid: 11451738
references.citation: Hypertens Pregnancy. 2004;23(1):47-60
references.pmid: 15117600
references.citation: J Soc Gynecol Investig. 2005 Sep;12(6):e45-50
references.pmid: 16046156
references.citation: Endothelium. 2006 May-Jun;13(3):227-31
references.pmid: 16840178
references.citation: Clin Chim Acta. 2003 Sep;335(1-2):109-15
references.pmid: 12927692
references.citation: Am J Hypertens. 2005 Mar;18(3):325-9
references.pmid: 15797648
references.citation: Int J Biochem Cell Biol. 2001 Oct;33(10):960-70
references.pmid: 11470230
references.citation: Am J Obstet Gynecol. 2002 Nov;187(5):1416-23
references.pmid: 12439541
references.citation: J Clin Pathol. 2004 Jun;57(6):577-84
references.pmid: 15166260
references.citation: Hypertens Pregnancy. 2001;20(2):185-94
references.pmid: 12044329
references.citation: J Clin Oncol. 2000 Mar;18(5):1135-49
references.pmid: 10694567
references.citation: J Hypertens. 1997 Oct;15(10):1049-54
references.pmid: 9350577
references.citation: BJOG. 2004 Sep;111(9):931-9
references.pmid: 15327607
references.citation: Hypertens Pregnancy. 2005;24(2):103-15
references.pmid: 16036395